Neogenomics Inc. (NASDAQ:NEO)

CAPS Rating: 1 out of 5

Recs

1
Player Avatar EnigmaDude (95.73) Submitted: 9/7/2012 12:07:01 PM : Outperform Start Price: $2.60 NEO Score: +12.30

Just starting to make a profit.Second Quarter 2012 Highlights:•57% test volume growth•49% revenue growth •58% gross profit growth•Net Income of $551,000, or $0.01 per share, vs. a loss of $(293,000), or ($0.01) per share in Q2 2011.•Adjusted EBITDA of $1.943 million, versus $0.483 million in Q2 2011

Featured Broker Partners


Advertisement